Mycronic AB (publ) provides sales guidance for the full year 2022. The Board of Directors' opinion that consolidated net sales for 2022 will be at a level of SEK 5 billion, based on exchange rates at the end of 2021.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
446.8 SEK | +1.18% |
|
+3.52% | +55.60% |
05-08 | Mycronic AB Approves Dividend, Payable on May 16, 2024 | CI |
05-02 | Mycronic AB Receives the First Order for an MMX Metrology System | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+55.60% | 4.13B | |
+39.11% | 142B | |
+38.15% | 101B | |
+32.59% | 23.85B | |
+14.95% | 20.77B | |
+50.00% | 11.3B | |
+20.50% | 9.87B | |
+23.89% | 9.01B | |
-25.74% | 5.9B | |
+71.91% | 5.38B |
- Stock Market
- Equities
- MYCR Stock
- News Mycronic AB
- Mycronic AB Provides Sales Guidance for the Full Year 2022